Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). H U Group Holdings's share price for the quarter that ended in Mar. 2026 was 円3191. H U Group Holdings's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 55 Mil. Therefore, H U Group Holdings's market cap for the quarter that ended in Mar. 2026 was 円177,056 Mil.
H U Group Holdings's quarterly market cap
declined
from Sep. 2025 (円194,051 Mil) to Dec. 2025 (円187,647 Mil) and
declined
from Dec. 2025 (円187,647 Mil) to Mar. 2026 (円177,056 Mil).
H U Group Holdings's annual market cap
increased
from Mar. 2024 (円138,752 Mil) to Mar. 2025 (円155,937 Mil) and
increased
from Mar. 2025 (円155,937 Mil) to Mar. 2026 (円177,056 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. H U Group Holdings's Enterprise Value for Today is 円208,540 Mil.
H U Group Holdings (TSE:4544) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
H U Group Holdings Market Cap Related Terms
H U Group Holdings Market Cap Historical Data
* Premium members only.
The historical data trend for H U Group Holdings's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, H U Group Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
H U Group Holdings Market Cap vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, H U Group Holdings's Market Cap distribution charts can be found below:
* The bar in red indicates where H U Group Holdings's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
H U Group Holdings's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
H U Group Holdings (TSE:4544) has a Market Cap of 円182,460 Mil as of Jul. 01, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on H U Group Holdings and its competitors. According to the industry distribution chart, H U Group Holdings ranks #50 out of 218 companies in the Medical Diagnostics & Research industry, placing it in the top 22.9%.
Is H U Group Holdings' Market Cap too high?
H U Group Holdings' current Market Cap is 円182,460 Mil. Based on the distribution chart, H U Group Holdings ranks #50 out of 218 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, H U Group Holdings has a GF Score™ of 68/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does H U Group Holdings' Market Cap compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, H U Group Holdings ranks #50 out of 218 companies for Market Cap. This places H U Group Holdings in the top 23% of its industry — outperforming the majority of peers. The industry median Market Cap is 58.23. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Diagnostics & Research company?
The median Market Cap among Medical Diagnostics & Research companies is 58.23, based on 218 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on H U Group Holdings and its competitors. For the Medical Diagnostics & Research industry, the median Market Cap is 58.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. H U Group Holdings's current Market Cap is 円182,460 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is H U Group Holdings stock overvalued right now?
Based on GuruFocus' analysis, H U Group Holdings (TSE:4544) is currently considered Modestly Overvalued. The stock's GF Value™ is 円2,773.07, compared to a current price of 円3,295.00 — trading 18.8% above its estimated fair value. The current Market Cap is 円182,460 Mil. H U Group Holdings' overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For H U Group Holdings (TSE:4544), the current Market Cap is 円182,460 Mil as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is H U Group Holdings (TSE:4544) Overvalued in 2026?
Based on GuruFocus' analysis, H U Group Holdings stock appears to be overvalued.
The current stock price of 円3,295.00 is trading 18.8% above its estimated GF Value™ of 円2,773.07.
GuruFocus considers H U Group Holdings to be Modestly Overvalued.
Key valuation signals for TSE:4544:
Market Cap: 円182,460 Mil
GF Value™: 円2,773.07 vs. price of 円3,295.00 (18.8% above fair value)
No single metric tells the full story. See the TSE:4544 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
H U Group Holdings Inc operates in the healthcare field, focusing on clinical laboratory testing and reagents. The company is engaged in four main businesses. The Clinical Laboratory Testing Business receives samples taken from patients at medical institutions to test for the disease and confirm the condition of the patient's health; In Vitro Diagnostics develops, manufactures, and sells testing reagents and equipment inside and outside Japan; Sterilization & Related Services Business provides a range of medical-related services including sterilization; and Emerging New Business & Others is a new business for future growth.
68GF Score
Get the complete analysis for TSE:4544
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4544 has been successfully added to your 
